azathioprine has been researched along with leflunomide in 72 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.78) | 18.2507 |
| 2000's | 24 (33.33) | 29.6817 |
| 2010's | 40 (55.56) | 24.3611 |
| 2020's | 6 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Knuckley, B; Luo, Y; Thompson, PR | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Gotoh, K; Hayashi, S; Inazu, M; Inoue, T; Ogawa, T | 1 |
| Kahan, BD | 1 |
| Pisetsky, DS; St Clair, EW | 1 |
| Reinhold-Keller, E | 1 |
| Brennan, DC; Hardinger, KL; Jendrisak, MD; Lowell, JA; Miller, BW; Schnitzler, MA; Shenoy, S; Wang, CD | 1 |
| Kushwaha, SS; Mayer, DF | 1 |
| Emery, P; Suarez-Almazor, M | 1 |
| Gladman, DD | 1 |
| Heath, M; Raugi, GJ | 1 |
| Issa, SN; Ruderman, EM | 1 |
| Cefle, A | 1 |
| Gross, WL; Hellmich, B; Lamprecht, P | 1 |
| de Groot, K; Jayne, D | 1 |
| Brocq, O; Cantagrel, A; Combe, B; Debiais, F; Deslandre, CJ; Kara-Terki, R; Kuntz, JL; Loet, XL; Mariette, X; Pavy, S; Perdriger, A | 1 |
| Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J | 1 |
| Matsuda, T; Ohtsubo, H | 1 |
| Glück, T; Müller-Ladner, U | 1 |
| Chambers, C; Johnson, D; Jones, KL; Koren, G; Tutuncu, ZN | 1 |
| Hartmann, U; Reuss-Borst, M; Schmitt, S | 1 |
| Brasington, R | 1 |
| Gergely, P; Poór, G | 1 |
| Mimori, T | 1 |
| Cantagrel, A; Claudepierre, P; Combe, B; Dernis, E; Flipo, RM; Gaudin, P; Goupille, P; Lavie, F; Le Loët, X; Maillefert, JF; Paul, C; Salliot, C; Saraux, A; Schaeverbeke, T; Tebib, J; Wendling, D | 1 |
| Förger, F; Østensen, M | 1 |
| Andrade, RJ; Cotta, J; Lucena, MA; Robles, M; Toscano, E | 1 |
| Karjalainen, A; Pettersson, T | 1 |
| Houtman, PM; Jansen, TL; Kwakernaak, AJ; Spoorenberg, JP; Weel, JF | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
| Kiss, CG; Kiss, E; Poór, G | 1 |
| Dábague Guzmán, J; Pedroza Granados, J; Zúñiga Varga, J | 1 |
| Artifoni, M; Puéchal, X | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Atkinson, A; Feldman, BM; Hawkins, C; Luca, NJ | 1 |
| Brun, JG; Kajalainen, A; Kautiainen, H; Knight, A; Ljung, L; Luukkainen, R; Nordström, D; Pettersson, T; Proven, A; Rantalaiho, V; van Vollenhoven, R | 1 |
| Bremer, JP; Gross, WL; Hellmich, B; Holl-Ulrich, K; Holle, JU; Laudien, M; Matthis, C; Metzler, C; Moosig, F; Nölle, B; Richardt, G | 1 |
| Baughman, RP; Lower, EE; Nunes, H; Sweiss, NJ | 1 |
| Bartsch, M; Effelsberg, NM; Hässler, F; Hentze, C; Miehle, N; Peter, HH; Salzer, U; Schlesier, M; Sic, H; Thiel, J; Venhoff, N; Voll, RE; Warnatz, K | 1 |
| Deneer, VH; Grutters, JC; van Moorsel, CH; Vorselaars, AD | 1 |
| Feldman, BM; Gross, WL; Guillevin, L; Hazlewood, GS; Metzler, C; Pagnoux, C; Tomlinson, GA | 1 |
| Dodam, JR; Nafe, LA; Reinero, CR | 1 |
| Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D | 1 |
| Chan, TM | 1 |
| López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
| Bao, H; Chen, YH; Hu, WX; Liu, ZH; Liu, ZZ; Wang, SF; Zhang, HT | 1 |
| Chen, CJ; Cheng, TT; Lin, JC; Lin, KM | 1 |
| Baughman, RP; Lower, EE | 1 |
| Craig, JC; Hodson, EM; Willis, NS; Wong, SC | 1 |
| Abraham, S; Augustin, M; Bieber, T; Elsner, P; Fölster-Holst, R; Homey, B; Kleinheinz, A; Novak, N; Schmitt, J; Stephan, V; Sticherling, M; Trautmann, F; Weidinger, S; Werfel, T | 1 |
| Fei, Y; Feng, R; Lai, Y; Peng, L; Wang, L; Wang, M; Zeng, X; Zhang, F; Zhang, P; Zhang, W; Zhang, X; Zhao, Y | 1 |
| Archer, TM; Mackin, AJ; Thomason, JM; Wills, RW | 1 |
| An, Y; Bi, L; Deng, X; Guo, J; Li, Y; Li, Z; Lin, J; Liu, B; Liu, X; Liu, Y; Lu, X; Mei, Y; Shen, H; Sun, L; Wang, G; Wang, H; Wang, M; Wang, Y; Xiao, W; Xie, R; Xu, D; Xu, H; Yang, X; Yao, Z; Yu, F; Zhang, J; Zhang, Z; Zhao, M; Zhao, Y; Zhou, Y; Zhu, P; Zuo, X | 1 |
| Archer, TM; Dandrieux, JRS; Firestone, S; Mansfield, CS; Narayanan, L | 1 |
| Akikusa, J; Alsaleem, A; Chiang, GPK; Laxer, RM; Lee, JJY; Limenis, E; Sontichai, W; Yeung, RSM | 1 |
| Bonnotte, B; Ghesquière, T; Greigert, H; Samson, M | 1 |
| Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ | 1 |
| Archer, TM; Boothe, DM; Cruz-Espindola, C; Fellman, C; Harmon, R; Mackin, AJ; Mulligan, C; Narayanan, L; Riggs, C; Thomason, JM; Wills, RW | 1 |
| Hammad, I; Porter, TF | 1 |
| Filippa, MG; Panopoulos, S; Sfikakis, PP; Spanos, E; Spanos, G; Tektonidou, MG; Yavropoulou, MP | 1 |
| Bao, C; Dai, L; Dai, M; Fu, Q; He, L; Li, Z; Lu, L; Sun, L; Wang, S; Wu, C; Xu, J; Zhu, X | 1 |
| Barrett, R; Culliford, D; Edwards, CJ; Fraser, S; Lin, SX | 1 |
32 review(s) available for azathioprine and leflunomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
Topics: Animals; Antimetabolites; Azathioprine; Biphenyl Compounds; Cell Differentiation; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytes; Lymphokines; Oligonucleotides, Antisense; Polyenes; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; Tacrolimus | 1994 |
Progress in the treatment of rheumatoid arthritis.
Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome | 2003 |
Rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2003 |
Psoriatic arthritis.
Topics: Adalimumab; Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimalarials; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Etanercept; Gold Sodium Thiomalate; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sulfasalazine; Tumor Necrosis Factor Decoy Receptors | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction.
Topics: Arthritis, Rheumatoid; Azathioprine; Disease Progression; Humans; Hydroxychloroquine; Immunologic Factors; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine | 2004 |
Advances in the therapy of Wegener's granulomatosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Etanercept; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Receptors, Tumor Necrosis Factor; Recurrence; Rituximab | 2006 |
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisolone; Receptors, Tumor Necrosis Factor; Vasculitis | 2005 |
[Effective combination therapy of TNF antagonists with DMARDs].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cysteine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Azathioprine; Biological Products; Cyclophosphamide; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Surgical Wound Infection; Tumor Necrosis Factor-alpha; Wound Healing | 2007 |
Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study.
Topics: Abnormalities, Drug-Induced; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Incidence; Information Services; Isoxazoles; Leflunomide; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Risk Assessment; Sulfasalazine; Teratogens | 2007 |
[New ways in the management of rheumatoid arthritis in Hungary].
Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Azathioprine; Chloroquine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Early Diagnosis; Etanercept; Humans; Hungary; Immunoconjugates; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prognosis; Receptors, Tumor Necrosis Factor; Rituximab; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
Management of RA medications in pregnant patients.
Topics: Abatacept; Acetaminophen; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Contraindications; Cyclosporine; Female; Gestational Age; Glucocorticoids; Humans; Immunoconjugates; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Rituximab; Sulfasalazine; Young Adult | 2009 |
[Diagnosis and management of small vessel vasculitides].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Progression; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Vasculitis | 2010 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
[Systemic autoimmune disorders and pregnancy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha | 2011 |
[Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Early Diagnosis; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Induction Chemotherapy; Isoxazoles; Leflunomide; Maintenance Chemotherapy; Methotrexate; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
How to treat refractory arthritis in lupus?
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis; Azathioprine; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoconjugates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2012 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Established and experimental medical therapy of pulmonary sarcoidosis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Dyspnea; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Positron-Emission Tomography; Quality of Life; Radiography, Thoracic; Research Design; Respiratory Function Tests; Sarcoidosis, Pulmonary; Therapies, Investigational; Treatment Outcome | 2013 |
Current therapy in sarcoidosis, the role of existing drugs and future medicine.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Sarcoidosis | 2013 |
Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome | 2014 |
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
Treatment of Sarcoidosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Clinical Trials as Topic; Drug Administration Schedule; Granuloma; Humans; Immunologic Factors; Infliximab; Isoxazoles; Leflunomide; Lung; Methotrexate; Mycophenolic Acid; Prednisone; Respiratory Function Tests; Sarcoidosis; Skin; Tomography, X-Ray Computed | 2015 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dexamethasone; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Isoxazoles; Leflunomide; Mycophenolic Acid; Nephrotic Syndrome; Prednisone; Randomized Controlled Trials as Topic; Remission Induction | 2016 |
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Churg-Strauss Syndrome; Cyclophosphamide; Drug Substitution; Drug Therapy, Combination; Forecasting; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Leflunomide; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Rituximab; Severity of Illness Index | 2019 |
[Treatment of giant cell arteritis].
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Azathioprine; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Leflunomide; Methotrexate; Prednisone; Ustekinumab | 2019 |
An Update on Biologic Agents During Pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
4 trial(s) available for azathioprine and leflunomide
| Article | Year |
|---|---|
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Interleukin-1; Remission Induction; Still's Disease, Adult-Onset; Sulfasalazine; Treatment Outcome | 2012 |
Effects of immunosuppressive agents on the hemostatic system in normal dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azathioprine; Blood Coagulation; Blood Platelets; Creatinine; Cross-Over Studies; Cyclosporine; Dogs; Female; Hemostasis; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Platelet Aggregation; Platelet Count; Prednisone; Thromboxane B2 | 2018 |
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study.
Topics: Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Leflunomide; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Treatment Outcome; Young Adult | 2019 |
Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up.
Topics: Adult; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Prednisone; Prospective Studies; Serum Albumin; Treatment Outcome | 2022 |
36 other study(ies) available for azathioprine and leflunomide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Topics: Arthritis, Rheumatoid; Chlortetracycline; Combinatorial Chemistry Techniques; Enzyme Inhibitors; Fluorescent Dyes; Hydrolases; Minocycline; Models, Biological; Molecular Structure; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Streptomycin; Tetracycline | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Azathioprine; Basement Membrane; Body Weight; Cholesterol; Fibrinogen; Glomerulonephritis; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Kidney Glomerulus; Leflunomide; Male; Methylprednisolone; Methylprednisolone Acetate; Proteinuria; Rabbits; Rats; Rats, Inbred Strains | 1991 |
[How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
Topics: Adjuvants, Immunologic; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Controlled Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction.
Topics: Adult; Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Mycophenolic Acid | 2002 |
Leflunomide and azathioprine combination in refractory adult-onset Still's disease.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Still's Disease, Adult-Onset | 2005 |
Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2006 |
Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Topics: Antibodies, Antinuclear; Arthritis; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Middle Aged; Polymyositis; Prednisolone | 2006 |
[Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report].
Topics: Adalimumab; Adolescent; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Aspartate Aminotransferases; Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Cortisone; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Isoxazoles; Leflunomide; Liver; Liver Function Tests; Methotrexate; Prednisolone | 2008 |
Disease-modifying antirheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine | 2009 |
Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinion.
Topics: Advisory Committees; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Evidence-Based Medicine; Expert Testimony; Follow-Up Studies; Glucocorticoids; Hospitals, Teaching; Humans; Isoxazoles; Joints; Leflunomide; Placebos; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2009 |
[Hepatotoxicity induced by new immunosuppressants].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Tumor Necrosis Factor-alpha | 2010 |
A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
Topics: Arthritis, Rheumatoid; Azathioprine; Biological Assay; CD4-Positive T-Lymphocytes; Female; Glucocorticoids; Humans; Immunity, Cellular; Interferon-gamma; Isoxazoles; Latent Tuberculosis; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Tuberculin Test; Tumor Necrosis Factor-alpha | 2011 |
Anti-signal recognition particle-positive juvenile polymyositis successfully treated with rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Child; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Muscle, Skeletal; Polymyositis; Rituximab; Signal Recognition Particle; Treatment Outcome | 2012 |
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
Topics: Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Cohort Studies; Cyclophosphamide; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2013 |
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; B-Lymphocyte Subsets; Cyclophosphamide; Female; Homeostasis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Rituximab | 2013 |
In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.
Topics: Aniline Compounds; Animals; Azathioprine; Cell Proliferation; Crotonates; Cyclosporine; Dexamethasone; Dogs; Flow Cytometry; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Nitriles; T-Lymphocytes; Toluidines | 2014 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lupus Nephritis; Male; Mycophenolic Acid; Nephrotic Syndrome; Podocytes; Prednisone; Proteinuria; Remission Induction; Retrospective Studies; Tacrolimus; Treatment Outcome | 2015 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Topics: Adult; Alitretinoin; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Leflunomide; Long-Term Care; Male; Methotrexate; Mycophenolic Acid; Prednisolone; Registries; Treatment Outcome | 2017 |
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Glucocorticoids; Glycosides; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Remission Induction; Treatment Outcome; Young Adult | 2018 |
Effect of immunosuppressive drugs on cytokine production in canine whole blood stimulated with lipopolysaccharide or a combination of ionomycin and phorbol 12-myristate 13-acetate.
Topics: Animals; Azathioprine; Cyclosporine; Dogs; Immunosuppressive Agents; Interferon-gamma; Interleukins; Ionomycin; Leflunomide; Lipopolysaccharides; Mycophenolic Acid; Prednisone; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2019 |
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Effects of oral administration of 5 immunosuppressive agents on activated T-cell cytokine expression in healthy dogs.
Topics: Administration, Oral; Animals; Azathioprine; Cross-Over Studies; Cyclosporine; Dogs; Female; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Leflunomide; Male; Mycophenolic Acid; Prednisone; Random Allocation; T-Lymphocytes | 2020 |
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cosyntropin; Glucocorticoids; Humans; Hydrocortisone; Hydroxychloroquine; Leflunomide; Methotrexate; Prednisolone; Recurrence; Tumor Necrosis Factor Inhibitors | 2022 |
Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset.
Topics: Azathioprine; Communicable Disease Control; COVID-19; Drug Prescriptions; Humans; Hydroxychloroquine; Leflunomide; Methotrexate; Pandemics; Sulfasalazine; Time Factors | 2022 |